ST. HELIER, Jersey--(BUSINESS WIRE)--Novocure, a commercial stage oncology company, was selected today as one of the World Economic Forum’s “Technology Pioneers”, a recognition of the world’s most innovative companies. Novocure is developing a novel, proprietary therapy called TTFields for the treatment of solid tumor cancers. TTFields is a low-toxicity anti-mitotic treatment that uses low-intensity, intermediate frequency, alternating electric fields to exert physical forces on key molecules inside cancer cells, disrupting the basic machinery necessary for normal cell division, leading to cancer cell death.
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.
